CINXE.COM

Surgery, Gastroenterology and Oncology

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> <title>Surgery, Gastroenterology and Oncology</title> <meta name="robots" content="index, follow" /> <meta name="rating" content="GENERAL" /> <meta http-equiv="pragma" content="NO-CACHE" /> <meta http-equiv="Content-Language" content="en" /> <link rel="stylesheet" type="text/css" media="all" href="/css/imp_style.css" /> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jquery/1.5.2/jquery.min.js"></script> <script type="text/javascript" src="/js/ddmegamenu.js"></script> <script type="text/javascript" src="/js/hw-local-menu.js"></script> </head> <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-38S8C89FSV"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-38S8C89FSV'); </script> <body> <div class="hw-gen-page" id="pageid-home"> <div id="header"> <h1> <a id="logo" href="/">Surgery, Gastroenterology and Oncology</a> </h1> <div style="float: right;text-align: right; font-size: 13px; line-height: 1.4em; padding-top: 20px;color: #0077C0; width: 40%;"> Official journal of the International Association of Surgeons, Gastroenterologists and Oncologists </div> <div class="topNav"> <ul class="button-list header-buttons" id="mainmenu"> <li class="home"><a href="/" title="Home"><span>Home</span></a></li> <li class=""><a href="/current-issue" title="Current Issue"><span>Current Issue</span></a></li> <li class=""><a class="" href="#" rel="archive[left]" title="Archive"><span>Archive</span></a></li> <li class=""><a href="/editorial-board" title="Editorial Board"><span>Editorial Board</span></a></li> <li class=""><a href="/app" title="Submit Article"><span>Submit Article</span></a></li> <li class=""><a class="" href="#" rel="for_authors[left]" title="Journal About"><span>About journal</span></a></li> <li class=""><a class="" href="#" rel="publisher-policies[left]" title="Publisher Policies"><span>Publisher Policies</span></a></li> <li class="last"><a href="/contact" title="Contact"><span>Contact</span></a></li> </ul> <div id="archive" class="mega journal"> <div class="column"> <ul> <li><a href="/archive">Archive</em></a></li> <li><a href="/ahead-of-print">Ahead of print</a></li> <li><a href="/current-medicine-around-the-world/">Current Medicine Around the World</a></li> <li><a href="/supplements/">Supplements</a></li> </ul> </div> </div> <div id="for_authors" class="mega journal"> <div class="column"> <ul> <li><a href="/for-authors/aims-and-scope">Aims and scope</em></a></li> <li><a href="/for-authors/information-for-authors">Information <em>for Authors</em></a></li> <li><a href="/for-authors/language-editing-service">Language Editing Service</a></li> <li><a href="/for-authors/copyright-agreement">Copyright Agreement</a></li> <li><a href="/for-authors/fees-and-funding">Fees and Founding</a></li> </ul> </div> </div> <div id="publisher-policies" class="mega journal"> <div class="column"> <ul> <li><a href="/publisher-policies/editorial-policies">Editorial policies </a></li> <li><a href="/publisher-policies/peer-review-policy">Peer review policy</a></li> <li><a href="/peer-review-process">Peer Review Process</a></li> <li><a href="/publisher-policies/ethics-policy">Ethics policy</a></li> <li><a href="/publisher-policies/advertising-policy">Advertising policy</a></li> <li><a href="/publisher-policies/corrections-retractions">Corrections, Retractions and Editorial expressions of concern</a></li> <li><a href="/publisher-policies/data-sharing-policy">Data sharing policy</a></li> <li><a href="/publisher-policies/authorship">Authorship</a></li> <li><a href="/publisher-policies/conflict-interest">Conflicts of interest</a></li> <li><a href="/publisher-policies/misconduct">Misconduct</a></li> <li><a href="/publisher-policies/appeals-and-complaints">Appeals and Complaints</a></li> <li><a href="/publisher-policies/licenses-and-copyright">Licenses and Copyright</a></li> </ul> </div> </div> </div> </div> <div id="content-block"> <div class="content-block-current"> <div class="masthead"></div> <div class="content-block-left"> <div class="cover-img-wrap"> <a id="cover-image" href="/current-issue"> <img src="/img/SGO-iasgo_nr4_2024.jpg" title="Current Issue Cover" alt="Current Issue Cover" style=" width: 264px; height: 372px;"/> </a> </div> <div class="issue-links"> <ul> <li><a href="/current-issue" title="Table of Contents">Table of Contents</a></li> </ul> </div> <div class="clear"></div> </div> <div class="content-block-right"> <span class="current-issue"><a href="/current-issue" class="">Current Issue</a></span> <h2 class="current-date"><a href="/current-issue" class="current-date-link"> Dec 2024</a><a href="/current-issue" style="margin-top: -3px;" class="view-toc btn btn-small btn-primary" title="View Table of Contents">View Current Issue</a></h2> <div class="current-issue-nav"><a href="/archive"><< Previous Issues</a></div> <div class="current-issue-nav"><a href="/supplements" style="float: right; margin-top: -65px; margin-right: 125px;">Supplements</a></div> <div class="current-issue-nav"><a href="/current-medicine-around-the-world" style="padding-left: 33px;padding-right: 33px;">Current Medicine around the world</a></div> <div class="thisweek"> <div class="thisweek-item" style="font-size:1.2em; text-align:center;text-decoration:none; "> <div class="title"> <a href="https://www.sgo-iasgo.com/article/fagotti-score-to-predict-the-possibility-of-optimal-cytoreduction-in-advanced-epithelial-ovarian-cancer"> The Fagotti s Score to Predict the Possibility of Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer </a> </div> <div class="excerpt" style="text-align: justify;"> <p>Ovarian cancer is the most common cause of lethality among women with gynecological cancers. In Europe, it ranks fifth in frequency in women after malignancies of the mammary gland, colon, lung and uterine body. Generally, it is diagnosed at an advanced stage (III-IV) due to the non-specificity of symptoms in the early stage and the lack of effective screening methods. The majority of patients with advanced epithelial ovarian cancer are indicated either for neoadjuvant chemotherapy followed by optimal cytoreduction or optimal cyto-reduction followed by adjuvant chemotherapy. This ....[<a href='https://www.sgo-iasgo.com/article/fagotti-score-to-predict-the-possibility-of-optimal-cytoreduction-in-advanced-epithelial-ovarian-cancer'>more</a>] </div> </div> </div> <div class="clear"></div> </div> </div> <div class="article_home"> <div class="header"> <a href="https://www.sgo-iasgo.com/article/evaluation-of-sentinel-lymph-node-biopsy-in-papillary-carcinoma-of-thyroid-during-total-thyroidectomy" style="text-decoration:none;"> Evaluation of Sentinel Lymph Node Biopsy in Papillary Carcinoma of Thyroid During Total Thyroidectomy </a> <br> <span xmlns="" class="meta"> <span class="author">Ahmed Ezzat Abd El-Rahiem Mohamed, Wafi Fouad Salib, Hesham Omran, George Magdy Halim Khella</span> <span class="divider"> <br> </span> <span class="pub-date">ORIGINAL PAPER, Dec 2024</span> <span class="divider"> <br> </span> <span class="pub-date"><b>Article DOI:</b> 10.21614/sgo-722</span> </span> </div> <div class="letters-item"> <a class="btn btn-primary pull-right" href="https://www.sgo-iasgo.com/article/evaluation-of-sentinel-lymph-node-biopsy-in-papillary-carcinoma-of-thyroid-during-total-thyroidectomy" title="Read article"><span class="icn-arrow"></span>Read article</a> <p><strong>Background: </strong>Lymph node metastases are very common in papillary thyroid carcinoma affecting the survival of patients. The appropriate management of cervical lymph nodes is very important. Therefore, this study evaluated the utility of sentinel lymph node biopsy (SLNB) using methylene blue in the central neck compartment. Objective: The aim of this study is to investigate the possibility of using the SLNB to predict micro metastasis in papillary carcinoma of thyroid to avoid the unnecessary central lymph node dissection.</p> <p><b>Patients and Methods:</b> This pro....[<a href='https://www.sgo-iasgo.com/article/evaluation-of-sentinel-lymph-node-biopsy-in-papillary-carcinoma-of-thyroid-during-total-thyroidectomy'>more</a>] </div> <div class="footer"> </div> </div> <div class="article_home"> <div class="header"> <a href="https://www.sgo-iasgo.com/article/risk-factors-and-morbidity-pattern-of-patients-with-peptic-ulcer-undergoing-endoscopic-examination" style="text-decoration:none;"> Risk Factors and Morbidity Pattern of Patients with Peptic Ulcer Undergoing Endoscopic Examination </a> <br> <span xmlns="" class="meta"> <span class="author">Rifqa Saad Abdulwahhab AlSalman, Mohamed Hesham Shawi Alshawi, Alaa Salman Dawood Alahmed, Omran Habib, Abbas Ali Mansour, Ahmed Salih Alshewered</span> <span class="divider"> <br> </span> <span class="pub-date">ORIGINAL PAPER, Dec 2024</span> <span class="divider"> <br> </span> <span class="pub-date"><b>Article DOI:</b> 10.21614/sgo-712</span> </span> </div> <div class="letters-item"> <a class="btn btn-primary pull-right" href="https://www.sgo-iasgo.com/article/risk-factors-and-morbidity-pattern-of-patients-with-peptic-ulcer-undergoing-endoscopic-examination" title="Read article"><span class="icn-arrow"></span>Read article</a> <p><strong>Background</strong>: the prevalence of peptic ulcer (PU) is declining in Western because of widespread use of Helicobacter pylori (H. pylori) eradication drugs, however, it still high in developing regions. The study aimed to explore certain aspects of cases with PU and to identify the predictors of PU related to risk factors.</p> <p><strong>Material and Methods:</strong> the study was conducted at the endoscopic unit at Al-Sadr Teaching Hospital. A cross-sectional study involving 152 cases who underwent endoscopic examination by specialist doctors. All patients were inte....[<a href='https://www.sgo-iasgo.com/article/risk-factors-and-morbidity-pattern-of-patients-with-peptic-ulcer-undergoing-endoscopic-examination'>more</a>] </div> <div class="footer"> </div> </div> <div class="article_home"> <div class="header"> <a href="https://www.sgo-iasgo.com/article/urine-neutrophil-gelatinase-associated-lipocalin-for-assessment-of-acute-kidney-injury-following-liver-transplantation" style="text-decoration:none;"> Urine Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury Following Liver Transplantation </a> <br> <span xmlns="" class="meta"> <span class="author">Abdel-Naser Abdel-Atty Gadallah, Amr Ragab Shalaby, Hanan Mosaad Bedair, Asmaa Yehia Ahmed Hikal, Hany Abd Elaziz Abd Elbary</span> <span class="divider"> <br> </span> <span class="pub-date">ORIGINAL PAPER, Dec 2024</span> <span class="divider"> <br> </span> <span class="pub-date"><b>Article DOI:</b> 10.21614/sgo-715</span> </span> </div> <div class="letters-item"> <a class="btn btn-primary pull-right" href="https://www.sgo-iasgo.com/article/urine-neutrophil-gelatinase-associated-lipocalin-for-assessment-of-acute-kidney-injury-following-liver-transplantation" title="Read article"><span class="icn-arrow"></span>Read article</a> <p><strong>Background:</strong> acute kidney injury (AKI) is a prevalent complication that occurs following liver transplantation (LT). Aim: to evaluate the value of urinary neutrophil gelatinase-associated lipocalin (UNGAL) in detecting AKI following LT.</p> <p><strong>Material and Methods:</strong> the present study adopted a randomized, prospective, double-</p> <p>blinded design. The trial was carried out on 38 patients who underwent evaluation for AKI</p> <p>following LT at Menoufia University&rsquo;s National Liver Institute. The study took place between January 2023 and June....[<a href='https://www.sgo-iasgo.com/article/urine-neutrophil-gelatinase-associated-lipocalin-for-assessment-of-acute-kidney-injury-following-liver-transplantation'>more</a>] </div> <div class="footer"> </div> </div> <div class="article_home"> <div class="header"> <a href="https://www.sgo-iasgo.com/article/therapeutic-impact-of-ras-testing-on-survival-outcomes-in-moroccan-metastatic-colorectal-cancer-patients" style="text-decoration:none;"> Therapeutic Impact of RAS Testing on Survival Outcomes in Moroccan Metastatic Colorectal Cancer Patients </a> <br> <span xmlns="" class="meta"> <span class="author">Sofia Fathi, Oussama Aazzane, Selma Guedanoui, Nezha Tawfiq, Souha Sahraoui, Fadila Guessous, Mehdi Karkouri</span> <span class="divider"> <br> </span> <span class="pub-date">ORIGINAL PAPER, Dec 2024</span> <span class="divider"> <br> </span> <span class="pub-date"><b>Article DOI:</b> 10.21614/sgo-718</span> </span> </div> <div class="letters-item"> <a class="btn btn-primary pull-right" href="https://www.sgo-iasgo.com/article/therapeutic-impact-of-ras-testing-on-survival-outcomes-in-moroccan-metastatic-colorectal-cancer-patients" title="Read article"><span class="icn-arrow"></span>Read article</a> <p><strong>Introduction:</strong> RAS mutations, particularly KRAS and NRAS mutations, are frequent drivers of metastatic colorectal cancer (mCRC) and confer resistance to anti-EGFR targeted therapy. This study investigated the impact of RAS molecular testing on treatment patterns and survival outcomes in Moroccan mCRC patients.</p> <p><strong>Material and Methods:</strong> A retrospective study was conducted among patients diagnosed mCRC and treated at Ibn Rochd University Hospital, Casablanca, Morocco, between 2019 and 2023. All patients received first-line chemotherapy followed b....[<a href='https://www.sgo-iasgo.com/article/therapeutic-impact-of-ras-testing-on-survival-outcomes-in-moroccan-metastatic-colorectal-cancer-patients'>more</a>] </div> <div class="footer"> </div> </div> <div class="clear"></div> </div> <div id="col-3"> <div class="rightside"> <div class="clearfix"></div> <div class=""> <form action="/search.php" method="get" class="s_form"> <span class="s_lab">Search The Journal</span><br> <input type="text" name="q" class="s_input" placeholder="Search article, author..." required> <input type="submit" class="s_btn" value="Search"> </form> </div> </div> <div class="rightside"> <!-- <a href="http://www.iasgo-ksgc2020.org" target="_blanc"> <img src="/img/iasgo-ksgc-2020.jpg" style="width:100%; margin-top: 5%; border-radius: 10px;"/> </a> --> <br> <a href="/video-articles/" style="margin-top:10px;"> <div style="float:left; margin-top: 0px;"> <img src="/img/play_icon.jpg" style="max-width:45px;" /> </div> <div style="padding-top: 13px;padding-left: 60px;"> <span id="video_abs_txt" style="font-size: 1.8em; color: #104b7d;">Watch Video Articles</span> </div> </a><br><hr> <span style="color: #0077c0;font-weight: bold;padding-left: 5px;">For Authors</span><br> <ul> <li style="line-height: 1.7em;text-decoration:none;"><a href="/for-authors/information-for-authors/">Information for Authors</a></li> <li style="line-height: 1.7em;text-decoration:none;"><a href="/for-authors/copyright-agreement/">Copyright agreement</a></li> <li style="line-height: 1.7em;text-decoration:none;"><a href="/for-authors/fees-and-funding/">Fees and Funding</a></li> </ul> <span style="color: #0077c0; line-height: 1.2em;"></span><br> <hr> <a href="/subscriptions/"> <br> <span style="margin-left: 20%; font-size: 1.4em;">Journal Subscriptions</span> <img src="/img/subscription.jpg" style="max-width:260px;" /> </a> <hr> <div class="header">Current Issue</div><br> <a href="/current-issue">Dec 2024</a><br><hr> <a href="/supplements">Supplements</a><br><hr> <a href="/for-authors/information-for-authors">Instructions for authors</a><hr> <a href="/app">Online submission</a><hr> <a href="/contact">Contact</a><hr> <!--<a href="/current-issue">Most viewed</a><hr>--> <div class="pr_issn"> ISSN: <span class="issn">2559 - 723X (print)</span><br><br> e-ISSN: <span class="issn">2601 - 1700 (online)</span><br><br> ISSN-L: <span class="issn">2559 - 723X</span><br><br> Journal Abbreviation: Surg. Gastroenterol. Oncol.<br><br> Surgery, Gastroenterology and Oncology (SGO) is indexed in: <ul><li>SCOPUS</li> <li style="padding-top: 5px;">EBSCO</li> <li style="padding-top: 5px;">DOI/Crossref</li> <li style="padding-top: 5px;">Google Scholar</li> <li style="padding-top: 5px;">SCImago</li> <li style="padding-top: 5px;">Harvard Library</li> <li style="padding-top: 5px;">Open Academic Journals Index (OAJI)</li> </ul> </div> <hr> <div class="pr_issn" style="line-height: 1.2em;"> <b>Open Access Statement</b><br><br> Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles. </div> <hr> <div class="pr_issn" style="line-height: 1.2em;"> <b>Journal Metrics</b><br><br> Time to first editorial decision: 25 days<br> Rejection rate: 61%<br> CiteScore: 0.2 </div> <hr> <div class="header"> <a href="/pdfs/IASGO_news.pdf" target="_blanc"><img src="/img/site/arrow_right.png" style="max-height:15px;"/> IASGO Society News</a> </div> <br> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2025/"> <img src="/img/iasgo_world_congres_2025.jpg" style="width:100%; margin-top: 1%; border-radius: 10px;"/> </a> <hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2025/">Meetings and Courses in 2025</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2024/">Meetings and Courses in 2024</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2023/">Meetings and Courses in 2023</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2022/">Meetings and Courses in 2022</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2021/">Meetings and Courses in 2021</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2020/">Meetings and Courses in 2020</a><hr> <a href="/meetings-and-courses-endorsed-by-iasgo-in-2019/">Meetings and Courses in 2019</a><hr> <a href="/verona-expert-meeting/">Verona expert meeting 2019</a><hr> <div class="header"> <a href="https://www.hpbsurgery.ro/scientific-events/" target="_blanc">ARCHBPTH,<br>Romanian Chapter of IASGO</a> </div> <hr> <a rel="license" href="http://creativecommons.org/licenses/by-nc/4.0/"><img alt="Creative Commons License" style="border-width:0" src="https://i.creativecommons.org/l/by-nc/4.0/88x31.png" /></a><br /> Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/ </div> </div> <div id="footer"> <div class="bar"> <div class="footer-group "> <div class="footer_m"> <a href="/">Home</a> | <a href="/current-issue">Current Issue</a> | <a href="/archive">Archive</a> | <a href="/editorial-board">Editorial Board</a> | <a href="/app">Submit Article</a> | <a href="/for-authors/information-for-authors"/>Information for authors</a> | <a href="/for-authors/language-editing-service/">Language Editing Service</a> | <a href="/for-authors/copyright-agreement/">Copyright Agreement</a> | <a href="/contact">Contact</a> | <a href="/map">Site map</a> </div> <ul class="issns"> <li> <span>Print ISSN: </span><span class="issn">2559 - 723X</span> </li> <li> <span>ISSN Online: </span><span class="issn">2601 - 1700</span> </li> <li> <span>Journal DOI: </span><span class="doi">10.21614/sgo</span> </li> </ul> </div> <div class="footer_l"> Surgery, Gastroenterology and Oncology<br> <span style="font-size:0.7em;">published by Celsius Publishing House | <a href="https://www.edituracelsius.ro" target="blanc">Editura Celsius</a></span> </div> <div><a href="/pdfs/Terms-Conditions-SGO-iasgo.pdf" target="_blanc">Terms & Conditions</a></div> <div class="footer-group footer-col-span"> <p class="copyright">Copyright &copy; 2025 by Surgery, Gastroenterology and Oncology. <a href="https://www.edituracelsius.ro" target="blanc">Editura Celsius</a></p> </div> </div> <div class="block-2 sb-div"></div> </div> </div> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10